Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models

Feingold syndrome is a skeletal dysplasia caused by mutations in MYCN or MIR17HG, but it is not clear if these mutations lead to pathology via a common molecular mechanism. Here, the authors show that mutations in MIR17HG lead to upregulated TGF-β signaling in limb mesenchymal cells, while mutations...

Full description

Bibliographic Details
Main Authors: Fatemeh Mirzamohammadi, Anastasia Kozlova, Garyfallia Papaioannou, Elena Paltrinieri, Ugur M. Ayturk, Tatsuya Kobayashi
Format: Article
Language:English
Published: Nature Portfolio 2018-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-018-03788-7
_version_ 1819039895928176640
author Fatemeh Mirzamohammadi
Anastasia Kozlova
Garyfallia Papaioannou
Elena Paltrinieri
Ugur M. Ayturk
Tatsuya Kobayashi
author_facet Fatemeh Mirzamohammadi
Anastasia Kozlova
Garyfallia Papaioannou
Elena Paltrinieri
Ugur M. Ayturk
Tatsuya Kobayashi
author_sort Fatemeh Mirzamohammadi
collection DOAJ
description Feingold syndrome is a skeletal dysplasia caused by mutations in MYCN or MIR17HG, but it is not clear if these mutations lead to pathology via a common molecular mechanism. Here, the authors show that mutations in MIR17HG lead to upregulated TGF-β signaling in limb mesenchymal cells, while mutations in MYCN downregulate PI3K signaling.
first_indexed 2024-12-21T09:00:29Z
format Article
id doaj.art-cce31e82791243b5bd7fb58a95b1fffa
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-21T09:00:29Z
publishDate 2018-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-cce31e82791243b5bd7fb58a95b1fffa2022-12-21T19:09:29ZengNature PortfolioNature Communications2041-17232018-04-019111010.1038/s41467-018-03788-7Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse modelsFatemeh Mirzamohammadi0Anastasia Kozlova1Garyfallia Papaioannou2Elena Paltrinieri3Ugur M. Ayturk4Tatsuya Kobayashi5Endocrine Unit, Massachusetts General Hospital, and Harvard Medical SchoolEndocrine Unit, Massachusetts General Hospital, and Harvard Medical SchoolEndocrine Unit, Massachusetts General Hospital, and Harvard Medical SchoolEndocrine Unit, Massachusetts General Hospital, and Harvard Medical SchoolMusculoskeletal Integrity Program, Hospital for Special SurgeryEndocrine Unit, Massachusetts General Hospital, and Harvard Medical SchoolFeingold syndrome is a skeletal dysplasia caused by mutations in MYCN or MIR17HG, but it is not clear if these mutations lead to pathology via a common molecular mechanism. Here, the authors show that mutations in MIR17HG lead to upregulated TGF-β signaling in limb mesenchymal cells, while mutations in MYCN downregulate PI3K signaling.https://doi.org/10.1038/s41467-018-03788-7
spellingShingle Fatemeh Mirzamohammadi
Anastasia Kozlova
Garyfallia Papaioannou
Elena Paltrinieri
Ugur M. Ayturk
Tatsuya Kobayashi
Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
Nature Communications
title Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
title_full Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
title_fullStr Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
title_full_unstemmed Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
title_short Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
title_sort distinct molecular pathways mediate mycn and myc regulated mir 17 92 microrna action in feingold syndrome mouse models
url https://doi.org/10.1038/s41467-018-03788-7
work_keys_str_mv AT fatemehmirzamohammadi distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels
AT anastasiakozlova distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels
AT garyfalliapapaioannou distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels
AT elenapaltrinieri distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels
AT ugurmayturk distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels
AT tatsuyakobayashi distinctmolecularpathwaysmediatemycnandmycregulatedmir1792micrornaactioninfeingoldsyndromemousemodels